Exceptional Ventures’ new healthtech fund targets prevention – and draws a line on AI: ‘Must be a human layer’

UK-based Exceptional Ventures has reached the first close of its new £40m fund – with backing from major institutional investors.

We sat down with Anna Fortuny-Gomez, science lead at the firm, to talk about the new fund, the good and bad of AI in healthtech, and the story of a House of Lords member that discovered a tumour using an experimental AI-powered body scanner.